Holocene Advisors, LP
- SEC CIK
- 0001700574
- Latest filing
- Aug 14, 2026
GSK holding history
GSK plc in every 13F filed by Holocene Advisors, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −5,518,433−100.0% | Sold out | Holders |
| Q1 2026 | 5,518,433 | $304.6M | 0.7% | −2,598,094−32.0% | Reduced | Holders |
| Q4 2025 | 8,116,527 | $398.0M | 0.8% | +1,016,107+14.3% | Added | Holders |
| Q3 2025 | 7,100,420 | $306.5M | 0.7% | +1,490,889+26.6% | Added | Holders |
| Q2 2025 | 5,609,531 | $215.4M | 0.5% | +304,489+5.7% | Added | Holders |
| Q1 2025 | 5,305,042 | $205.5M | 0.6% | +4,792,922+935.9% | Added | Holders |
| Q4 2024 | 512,120 | $17.3M | 0.1% | +446,819+684.2% | Added | Holders |
| Q3 2024 | 65,301 | $2.67M | <0.1% | −5,624,394−98.9% | Reduced | Holders |
| Q2 2024 | 5,689,695 | $219.1M | 0.9% | −3,029,949−34.7% | Reduced | Holders |
| Q1 2024 | 8,719,644 | $373.8M | 1.4% | +495,096+6.0% | Added | Holders |
| Q4 2023 | 8,224,548 | $304.8M | 1.2% | +3,210,489+64.0% | Added | Holders |
| Q3 2023 | 5,014,059 | $181.8M | 0.8% | +2,096,223+71.8% | Added | Holders |
| Q2 2023 | 2,917,836 | $104.0M | 0.5% | +1,735,217+146.7% | Added | Holders |
| Q1 2023 | 1,182,619 | $42.1M | 0.2% | +1,182,619 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −250,000−100.0% | Sold out | Holders |
| Q2 2022 | 250,000 | $10.9M | 0.1% | +250,000 | New | Holders |